Predictors and prognosis of no-reflow during primary percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Research

Background:

• The no-reflow phenomenon is a frequent complication in ST-elevation myocardial infarction (STEMI) patients receiving primary reperfusion therapy.
• Understanding predictors and outcomes of no-reflow is crucial for improving patient management.

Purpose of the Study:

• To identify clinical, angiographic, and procedural predictors of the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
• To assess the impact of no-reflow on in-hospital mortality.

Main Methods:

• Prospective observational study involving 410 STEMI patients undergoing PPCI.
• Data collection included clinical presentation, angiographic findings, procedural details, and in-hospital outcomes.

Main Results:

• Diabetes mellitus, late presentation, higher Killip class, anterior wall infarction, proximal occlusion, high-grade thrombus, and left ventricular systolic dysfunction were associated with suboptimal flow.
• Independent predictors of no-reflow included diabetes mellitus, high thrombus burden, prolonged ischemic time, and low left ventricular ejection fraction.
• No-reflow was associated with more than double the in-hospital mortality compared to normal flow.

Conclusions:

• Several factors predict the no-reflow phenomenon in STEMI patients undergoing PPCI.
• No-reflow significantly increases in-hospital mortality, highlighting the need for strategies to prevent or mitigate this complication.